Target Information

The seventh investment from the Private Equity Fund Metrika has culminated in the establishment of an industrial holding company aimed at creating a center of excellence within the dental implant and prosthetics market. On June 29, 2023, Metrika, under the leadership of partners Marco Giuseppini and Nicola Pietralunga, acquired a majority stake in Agliati, a leading firm specializing in the design and production of dental implants, prosthetic components, and surgical instrumentation kits for third parties. The Agliati family will retain a minority stake in the holding, ensuring operational continuity and managerial involvement while supporting Metrika's vision of establishing the first industrial hub for dental and prosthetic implant services in Italy.

Founded in 1973 in Ambivere (BG), Agliati is celebrating its 50th anniversary and boasts over 30 years of experience in precision mechanics. It has developed a recognized expertise in producing dental implants and prosthetic components, backed by a highly technological manufacturing facility that ensures high-quality and customized products. The company serves major national and international brands. Continuous investment in research and development has allowed Agliati, led by Ignazio Agliati and his qualified team, to also penetrate the orthopedic prosthetics market. Agliati is certified under ISO 9001, ISO 13485, and EU MDR 2017/745, the new European regulations for medical devices.

Industry Overview in Italy

Italy's dental and prosthetic implant market is characterized by a significant level of fragmentation, making it ripe for consolidation. This sector requires high-quality standards and customization, both of which are hallmarks of traditional Italian family-run businesses. Companies in the industry focus on innovation and adaptation to changing regulations, positioning them as leaders in quality and customer service.

The Italian healthcare system is robust, with a growing demand for implantological procedures fueled by an aging population and increased awareness of dental and orthopedic health. This presents substantial opportunities for companies that can navigate the regulatory landscape and leverage technological advancements in production methods.

Moreover, the shift towards preventive healthcare and personal aesthetics is leading to a surge in procedures involving dental implants and prosthetic solutions. This trend is bolstered by advancements in technology, such as 3D printing and customized solutions, providing a competitive edge to companies adept in these areas.

With a strong focus on innovation and quality, Italian firms are increasingly looking to expand their offerings and tap into adjacent markets. This is where strategic M&A initiatives become pivotal, allowing for rapid growth and diversification in product lines and market reach.

Rationale Behind the Deal

The strategic rationale behind Metrika's acquisition of Agliati is to capitalize on the opportunities within the fragmented dental and prosthetic market. By establishing a holding company that consolidates expertise, Metrika aims to provide a broader array of solutions catering to both dental and orthopedic sectors.

This initiative is designed to expand Agliati’s production capacity through investments in new machinery and facilities, while the strategic growth plan includes mergers and acquisitions to solidify its foothold in the Italian market. Additionally, introducing key management personnel will be crucial in driving the operational success of the holding and its subsidiaries.

Investor Information

Founded by Marco Giuseppini, who serves as the CEO, Metrika is a private equity firm focused on investments in the industrial sector. The firm specializes in creating value through strategic partnerships and operational improvements. Metrika has built a strong track record of fostering innovation and operational excellence within its portfolio companies.

Metrika partners closely with management teams of its portfolio companies, providing not just financial backing but also expertise in strategic growth, operational efficiency, and market evolution. Their investment in Agliati underscores their commitment to driving transformation in the dental and prosthetic industries.

View of Dealert

This acquisition represents a significant opportunity for both Metrika and Agliati, effectively positioning the new holding company as a leader in the dental and prosthetic sectors. The combination of Agliati’s solid reputation and Metrika’s strategic vision creates a promising platform for growth and innovation.

The planned emphasis on expanding production capacity and pursuing strategic M&A will likely enhance the firm’s competitive position in a growing market. Additionally, the emphasis on quality and customization aligns well with current trends, suggesting that this investment could yield substantial returns over time.

Furthermore, the involvement of the Agliati family in the management structure will help ensure continuity and operational excellence, which is pivotal for maintaining relationships with existing clients and tapping into new markets. Their established brand recognition serves as an invaluable asset in competitive landscapes.

In conclusion, this deal is poised to be beneficial for Metrika, paving the way for becoming a leader in both the national and international markets of dental and orthopedic prosthetics. If executed effectively, this investment could contribute significantly to future growth and profitability.

View Original Article